ORAL DRUG CAPSULE COMPONENT INCORPORATING A COMMUNICATION DEVICE

• US 20080175898A1
• Filed: 01/16/2008
• Published: 07/24/2008
• Est. Priority Date: 01/16/2007
• Status: Abandoned Application

• Current Assignee: Dow Global Technologies LLC (Dow, Inc.)
• Original Assignee: Dow Global Technologies, Inc. (Dow, Inc.)
• Inventors: Mercure, Peter K., Jones, Christopher Michael, White, Douglas Paul
• Application Number:
  US12/015,201
• Publication Number:
  US 20080175898A1
• Time in Patent Office: Days
• US Class Current: 424/452
• CPC Class Codes: A61B 5/0002 Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network A61B5/07 takes precedence; transmission systems for measured values G08C; transmission H04B; transmission of digital information H04L; wireless communication networks H04W
• CPC Class Codes: A61B 5/06 Devices, other than using radiation, for detecting or locating foreign bodies for removing same A61B17/50 ; determining position of probes within or on the body of the patient
• CPC Class Codes: A61B 5/061 Determining position of a probe within the body employing means separate from the probe, e.g. sensing internal probe position employing impedance electrodes on the surface of the body A61B1/00158 takes precedence
• CPC Class Codes: A61B 5/42 Detecting, measuring or recording for evaluating the gastrointestinal, the endocrine or the exocrine systems A61B1/00, A61B5/4857, A61B5/486, A61B5/4866, A61B5/4869 take precedence
• CPC Class Codes: A61B 5/4833 Assessment of subject's compliance to treatment
• CPC Class Codes: A61B 5/4839 combined with drug delivery
• CPC Class Codes: A61J 2200/30 Compliance analysis for taking medication
• CPC Class Codes: A61J 3/007 Marking tablets or the like apparatus for printing on tablets or the like B41F17/36
• CPC Class Codes: A61K 9/0009 involving or responsive to electricity, magnetism or acoustic waves; Galenical aspects of sonophoresis, iontophoresis, electroporation or electroosmosis microelectromechanical systems A61K9/0097
• CPC Class Codes: A61K 9/4808 characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release capsules filled with granules or microparticles A61K9/16; filled with microcapsules or coated microparticles A61K9/50; with mixture of different granules, microcapsules, (coated) microparticles A61K9/5084
• CPC Class Codes: G16H 20/13 delivered from dispensers

Abstract

An improved upper capsule portion (62) of an oral drug delivery capsule (60) that includes an upper capsule portion (62) and a lower cup shaped capsule portion (64), the lower cup shaped capsule portion (64) containing a medical formulation (66), the lower capsule portion (64) being made of a material that disperses in gastrointestinal fluid, the lower capsule portion (64) having a mouth, the upper capsule portion (62) dimensioned to engage with the mouth of the lower capsule portion (64). The improvement is the positioning of a communication device, such as an RFID tag (90), on or integrally with the upper capsule portion (62) so that the communication device can communicate that the oral drug delivery capsule has been ingested. An alternate embodiment with an improved lower capsule portion is also disclosed.

Claims

1. An improved upper capsule portion of an oral drug delivery capsule comprising;

an upper capsule portion and a lower cup shaped capsule portion for containing a medical formulation, said lower capsule portion being made of a material that disperses in gastrointestinal fluid, said lower capsule portion having a mouth, said upper capsule portion being dimensioned to engage with said mouth of said lower capsule portion; and

a communication device positioned on or integrally with said upper capsule portion whereby said communication device can communicate that the oral drug delivery capsule has been ingested.

2. The improved upper capsule portion of claim 1, wherein said communication device is selected from the group consisting of an RFID tag, an electromagnetic signaling device, a magnetic device, an infrared emitting device and an ultrasonic device.

3. The improved upper capsule portion of claim 1, wherein the upper capsule portion is shaped so that the oral drug delivery capsule is tamper-proof.

4. The improved upper capsule portion of claim 2, wherein the upper capsule portion is shaped so that the oral drug delivery capsule is tamper-proof.

5. The improved upper capsule portion of claim 1 further comprising a receiver located on or near a person for communication with the communication device of the upper capsule portion.

6. The improved upper capsule portion of claim 2, further comprising a receiver located on or near a person for communication with the communication device of the upper capsule portion.

7. The improved upper capsule portion of claim 3, further comprising a receiver located on or near a person for communication with the communication device of the upper capsule portion.

9. The improved lower capsule portion of claim 5, wherein said communication device is selected from the group consisting of an RFID tag, an electromagnetic signaling device, a magnetic device, an infrared emitting device and an ultrasonic device.

11. The improved lower capsule portion of claim 9, wherein said upper capsule portion is shaped so that the oral drug delivery capsule is tamper-proof.

13. The improved lower capsule portion of claim 9, further comprising a receiver located on or near a person for communication with said communication device of said lower capsule portion.

8. An improved lower capsule portion of an oral drug delivery capsule comprising:

an upper capsule portion and a lower capsule portion, said lower capsule portion for containing a medical formulation, said upper capsule portion being made of a material that disperses in gastrointestinal fluid, said lower capsule portion having a mouth, said upper capsule portion being dimensioned to engage with said mouth of said lower capsule portion; and

a communication device positioned on or integrally with said lower capsule portion so that said communication device can communicate that the oral drug delivery capsule has been ingested.

10. The improved lower capsule portion of claim 8, wherein said upper capsule portion is shaped so that the oral drug delivery capsule is tamper-proof.

12. The improved lower capsule portion of claim 8, further comprising a receiver located on or near a person for communication with said communication device of said lower capsule portion.

14. The improved lower capsule portion of claim 10, further comprising a receiver located on or near a person for communication with said communication device of said lower capsule portion.

15. An improved oral drug delivery system, the oral drug delivery system selected from the group consisting of a capsule and a tablet, wherein the improvement comprises a communication device attached to the capsule or tablet so that the communication device communicates that the capsule or tablet has been ingested.

16. The improved oral delivery system of claim 15, wherein said communication device is selected from the group consisting of an RFID tag, an electromagnetic signaling device, a magnetic device, an infrared emitting device and an ultrasonic device.

17. The improved oral delivery system of claim 15, further including an upper capsule portion, said upper capsule portion being shaped so that the oral drug delivery capsule is tamper-proof.

18. The improved oral delivery system of claim 15, further including a lower capsule portion, said lower capsule portion being matable with said upper capsule portion.

19. The improved oral delivery system of claim 18, further comprising a receiver located on or near a person for communication with said communication device of said lower capsule portion.

20. The improved oral delivery system of claim 15 wherein said communication device further includes an antenna.